Update on the Phase 4 Confirmatory Study of ADUHELM®

Go back to Update on the Phase 4 Confirmatory Study of ADUHELM®
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 249.61 -4.23 (1.67%)
Previous Close $253.84    52 Week High $333.65 
Open $251.66    52 Week Low $223.02 
Day High $252.27    P/E 31.96 
Day Low $249.61    EPS $7.81 
Volume 26,438